| Advanced Lipoprotein Fingerprinting is a more | | | | is low and patient is not fasting, consider |
| precise cholesterol test that allows doctors | | | | checking total cholesterol and high-density |
| to identify health risks that traditional | | | | lipoprotein (HDL) cholesterol. |
| screens miss. Doctors now have a precise | | | | |
| reading not only of a patient's cholesterol | | | | General Awareness Activities: |
| levels but other independent risk factors | | | | |
| known to be associated with heart disease. | | | | Employer, School and Community Education |
| | | | Awareness Activities |
| The process separates lipids in the blood to | | | | |
| create a detailed cholesterol profile that | | | | Many educational and medical individuals are |
| helps doctors identify patients at risk for | | | | playing very impressive and crucial role by |
| heart disease. The detailed graph allows a | | | | putting their efforts in helping to increase |
| doctor to precisely analyze a patient's | | | | the number of children and adults to present |
| overall risk profile and monitor the | | | | themselves for appropriate lipid screenings. |
| effectiveness of a diet or treatment regimen. | | | | |
| | | | Awareness initiative programming conducted |
| This advanced analytical techniques that can | | | | includes: |
| help doctors diagnose early warning signs for | | | | |
| coronary heart disease, which kills more than | | | | • Posters for company bulletin boards |
| 2,600 Americans a day, according to the | | | | |
| American Heart Association. High LDL | | | | • General screening information "tents" |
| cholesterol is a major cause of coronary | | | | for tables in reception areas, cafeterias, |
| heart disease, according to the National | | | | employee lounges, locker rooms, and other |
| Cholesterol Education Program. | | | | such places |
| | | | |
| Aiming to identify early risk factors, the | | | | • Incentives to increase compliance |
| National Cholesterol Education Program issued | | | | with and awareness of guideline screening |
| guidelines calling for more comprehensive | | | | recommendations Information on the importance |
| cholesterol screens as well as other risk | | | | of regular lipid screening can be included as |
| factors not included in the cholesterol | | | | part of a larger health promotion/disease |
| screen. | | | | prevention initiative which includes not only |
| | | | cholesterol and healthy lifestyles but aware |
| Early detection, particularly in youth, is | | | | people of heart diseases and appropriate |
| the key to slowing down the development of | | | | health care utilization as well. |
| heart disease in later life. Advanced | | | | |
| cholesterol screening is a valuable tool that | | | | Health care providers should: |
| is gaining acceptance among medical insurers. | | | | |
| | | | • Establish a process to identify those |
| Texas A&M University researchers created | | | | needing cholesterol screening |
| Advanced Lipoprotein Fingerprinting as a more | | | | |
| precise cholesterol test that allows doctors | | | | • Make educational brochures available |
| to identify health risks that traditional | | | | at time of visit |
| screens miss. LipidLabs further refined the | | | | |
| Advanced Lipoprotein Fingerprinting Process | | | | • Select educational materials based on |
| and made Advanced Lipoprotein Fingerprinting | | | | a nutrition and exercise assessment |
| available for commercialization. LipidLabs' | | | | |
| results translate to more accurate and | | | | • Utilize a system encouraging patients |
| specific data on which to make clinical | | | | to attend classes if laboratory results |
| judgments and guide patient therapy and | | | | suggest benefit from changing nutritional and |
| prevention at reasonable costs. | | | | or exercise behaviors. |
| | | | |
| Clinical Highlights: | | | | Doctors somethimes also make visits to |
| | | | offices and schools for conducting lipid |
| 1. Screen men over age 34 and women over age | | | | screenings. |
| 44 every five years. | | | | |
| | | | Total Cholesterol >200; LDL >130; HDL200? |
| 2. The decision to screen men age 20 to 34 | | | | |
| years, women age 20 to 44 years and anyone | | | | Individuals with a total cholesterol less |
| over 75 years should be based on individual | | | | than or equal to 200 mg/dL (and |
| preferences of patient and provider. | | | | HDL-cholesterol of 40 mg/dL or above or |
| | | | triglycerides less than or equal to 200) have |
| 3. Measure cholesterol fractionation and | | | | a desirable cholesterol level are advised to |
| provide nutrition and exercise assessment | | | | repeat cholesterol fractionation in five |
| every five years. If likelihood of follow-up | | | | years. |